↓ Read PDF
01 · ABSTRACT

Abstract

Purpose of the study: The objective of this study is to evaluate subjective changes in sleep, insomnia, and dream production in chronic benzodiazepine (BZ) users enrolled in a withdrawal program. BZs, widely prescribed to treat insomnia, are likely to alter sleep structure. This research aims to determine the extent to which discontinuing these treatments promotes the restoration of sleep and dream processes. Method: The study is based on data from a drug withdrawal program combined with Cognitive Behavioral Therapy for Insomnia (CBT-I), including 107 participants presenting prolonged use of BZs. Assessments were conducted at three time points: before the program (T0), after 3 months on the program (T1), and after 12 months (T2). The main variables included the severity of insomnia (ISI), sleepiness (Epworth), fatigue (Pichot), sleep quality and efficiency (SQ and SE), sleep parameters (diary), and the frequency of dreams and nightmares (non-standardized questions; NFQ). The analyses were conducted using repeated measures ANOVAs and post hoc tests, with withdrawal status and sleep restriction practice as between-subject factors. Results: The majority of participants managed to stop using BZs completely or reduce their consumption by more than 50%. Overall, all sleep and dream parameters showed improvement with BZs reduction or discontinuation, except for daytime sleepiness. The number of individuals experiencing chronic nightmares also decreased. Individuals who completely stopped using BZs showed a greater reduction in the severity of their insomnia. These improvements associated with BZs reduction were independent of continued use of CBT-I methods. Conclusion: These results indicate that the observed benefits to sleep quality and wellness, including dream activity, found both in the medium and long term, were mainly attributed to BZs discontinuation, rather than to the application of behavioral techniques (which may hence serve rather to achieve said discontinuation). Discontinuing BZs, preferably through gradual tapering, therefore appears beneficial for improving insomnia and regulating dream activity.
↓ Read PDF
02 · OJS METADATA

Keywords

BenzodiazepineDependenceInsomniaCognitive Behavioral TherapyTapering.
03 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 14 No 3 (2026): Vol.14, Issue 3, March 2026
SectionResearch Articles
Published01 April 2026
DOI10.18103/mra.v14i3.7329
ISSN2375-1924
04 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

BP

Benjamin Putois

Lyon Neuroscience Research Center, CNRS UMR 5292 - INSERM U1028 - Lyon 1 University, 95 Bd Pinel, 69500 Bron, France.

MG

Marie-Paule Gustin

Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID), International Center for Infectiology Research (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Lyon, France.

FC

Flore Collong

Faculty of Psychology, UniDistance Suisse, 3900 Brig, Switzerland.

HB

Helene Bastuji

Lyon Neuroscience Research Center, CNRS UMR 5292 - INSERM U1028 - Lyon 1 University, 95 Bd Pinel, 69500 Bron, France.

RA

Royce Anders

Univ Paul Valery Montpellier 3, Univ. Montpellier, EPSYLON EA 4556, F34000, Rte de Mende, Montpellier, France.

MH

Melanie Havy

Faculty of Psychology, UniDistance Suisse, 3900 Brig, Switzerland.

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗